[go: up one dir, main page]

ATE555793T1 - Verringerung der nebenwirkungen von aromatase- hemmern zur behandlung von brustkrebs - Google Patents

Verringerung der nebenwirkungen von aromatase- hemmern zur behandlung von brustkrebs

Info

Publication number
ATE555793T1
ATE555793T1 AT06804410T AT06804410T ATE555793T1 AT E555793 T1 ATE555793 T1 AT E555793T1 AT 06804410 T AT06804410 T AT 06804410T AT 06804410 T AT06804410 T AT 06804410T AT E555793 T1 ATE555793 T1 AT E555793T1
Authority
AT
Austria
Prior art keywords
treatment
breast cancer
side effects
reducing
aromatase inhibitors
Prior art date
Application number
AT06804410T
Other languages
English (en)
Inventor
Stephen Birrell
Original Assignee
Chavah Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005905768A external-priority patent/AU2005905768A0/en
Application filed by Chavah Pty Ltd filed Critical Chavah Pty Ltd
Priority claimed from PCT/AU2006/001539 external-priority patent/WO2007045027A1/en
Application granted granted Critical
Publication of ATE555793T1 publication Critical patent/ATE555793T1/de

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06804410T 2005-10-19 2006-10-18 Verringerung der nebenwirkungen von aromatase- hemmern zur behandlung von brustkrebs ATE555793T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2005905768A AU2005905768A0 (en) 2005-10-19 Therapeutic methods, compositions and kits
US73266205P 2005-11-03 2005-11-03
US79830806P 2006-05-08 2006-05-08
PCT/AU2006/001539 WO2007045027A1 (en) 2005-10-19 2006-10-18 Reduction of side effects from aromatase inhibitors used for treating breast cancer

Publications (1)

Publication Number Publication Date
ATE555793T1 true ATE555793T1 (de) 2012-05-15

Family

ID=40214740

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06804410T ATE555793T1 (de) 2005-10-19 2006-10-18 Verringerung der nebenwirkungen von aromatase- hemmern zur behandlung von brustkrebs

Country Status (3)

Country Link
CN (1) CN101340914B (de)
AT (1) ATE555793T1 (de)
NZ (1) NZ567816A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113967217A (zh) * 2021-12-10 2022-01-25 山东山大附属生殖医院有限公司 来曲唑联合十一酸睾酮在弱精子症治疗中的应用

Also Published As

Publication number Publication date
CN101340914A (zh) 2009-01-07
NZ567816A (en) 2011-08-26
CN101340914B (zh) 2011-08-10

Similar Documents

Publication Publication Date Title
TN2010000209A1 (en) Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
TW200501960A (en) Synergistic kits and compositions for treating cancer
AU2016204344A1 (en) Improved methods and compositions for wound healing
MX2010010300A (es) Formas de sal de inhibidores del objetivo de rapamicina en mamiferos.
NO20092637L (no) Fremgangsmater for behandling
ATE553198T1 (de) Behandlung von krebs durch die kombinierte hemmung der proteasom- und telomeraseaktivitäten
EA200870019A1 (ru) Лактамовые соединения и способы их применения
AP1913A (en) Substituted benzazoles and use thereof as raf kinase inhibitors
PH12014500053A1 (en) Proteasome inhibitors
MX2011006685A (es) Inhibidores de metaloproteinas de matriz de membrana tipo-1 y sus usos.
UA95310C2 (ru) Композиция, содержащая ингибитор chk1 и циклодекстрин, для лечения рака
MX2007016322A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
NO20060398L (no) Anvendelse av en kombinasjon av en epidermal vekstfaktor reseptor kinase inhibitor og cytotoksiske midler for behandling og hemming av kreft
IL174965A0 (en) SUBSTITUTED BENZAZOLES AND USE THEREOF AS INHIBITORS OF Raf KINASE
ATE456571T1 (de) Proteasom-hemmer und verwendungsverfahren dafür
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
EA200800755A1 (ru) Ikk ингибиторы, предназначенные для лечения эндометриоза
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
UA94922C2 (ru) Способ регулирования специфичности сигнализации тканевого фактора у млекопитающего, которое нуждается в этом, способ идентификации агента, который специфически ингибирует сигнализацию тканевого фактора
MX2009005550A (es) Inhibidores de fosfatasa de proteina tirosina para la promocion de la hipertrofia cardiaca fisiologica.
BRPI0511475A (pt) combinação, composição farmacêutica, uso de uma combinação, e, método para o tratamento de cáncer
EA200800766A1 (ru) Ингибиторы pi3k для лечения эндометриоза
DK2041181T3 (da) Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi
ATE555793T1 (de) Verringerung der nebenwirkungen von aromatase- hemmern zur behandlung von brustkrebs